Correlation Between DatChat and Virpax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both DatChat and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DatChat and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DatChat and Virpax Pharmaceuticals, you can compare the effects of market volatilities on DatChat and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DatChat with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of DatChat and Virpax Pharmaceuticals.
Diversification Opportunities for DatChat and Virpax Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between DatChat and Virpax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding DatChat and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and DatChat is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DatChat are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of DatChat i.e., DatChat and Virpax Pharmaceuticals go up and down completely randomly.
Pair Corralation between DatChat and Virpax Pharmaceuticals
If you would invest 25.00 in Virpax Pharmaceuticals on May 17, 2025 and sell it today you would earn a total of 0.00 from holding Virpax Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 1.64% |
Values | Daily Returns |
DatChat vs. Virpax Pharmaceuticals
Performance |
Timeline |
DatChat |
Virpax Pharmaceuticals |
Risk-Adjusted Performance
Weakest
Weak | Strong |
DatChat and Virpax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DatChat and Virpax Pharmaceuticals
The main advantage of trading using opposite DatChat and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DatChat position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.DatChat vs. Intelligent Protection Management | DatChat vs. Sphere 3D Corp | DatChat vs. Society Pass | DatChat vs. Context Therapeutics |
Virpax Pharmaceuticals vs. MetaVia | Virpax Pharmaceuticals vs. Indaptus Therapeutics | Virpax Pharmaceuticals vs. Pasithea Therapeutics Corp | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |